The mechanisms by which obesity contributes to diabetic phenotypes remain unclear. We evaluated the role of protein kinase A (PKA) signaling events in mediating diabetes associated with obesity. PKA comprises two regulatory subunits and two catalytic subunits and is activated by cAMP. The RII␤ regulatory subunit is abundantly expressed in adipose tissue and brain. Knockout mice lacking this subunit are lean and display remarkable resistance to diet-induced obesity. We investigated whether these mice were also resistant to diet-induced diabetes and whether this effect was dependent on reduced adiposity. Mice were fed a high-fat, high-carbohydrate diet and weight gain and diabetes phenotypes were examined. RII␤ ؊/؊ mice displayed decreased body weights, reduced insulin levels, improved insulin sensitivity, and improved total-body glucose disposal as compared with wild-type controls. Plasma levels of VLDL and LDL cholesterol were also reduced in high fat-fed RII␤ ؊/؊ mice compared with wild-type mice. Taken together, these data demonstrate that loss of RII␤ protects mice from diet-induced obesity, insulin resistance, and dyslipidemia. Diabetes 50:2555-2562, 2001 R ecent reports indicate that obesity is rapidly increasing in industrialized nations. More than 35% of American adults are now considered overweight or obese (1), and obesity is an important contributing factor to the development of type 2 diabetes (2-4). Dyslipidemia is often observed in association with obesity and diabetes and is a significant contributor to the increased mortality observed in diabetic patients (5,6). Characteristics of type 2 diabetes include impaired glucose disposal, diminished insulin production, and increased hepatic glucose output. The mechanisms by which obesity contributes to these phenotypes remain unclear (7).
R
ecent reports indicate that obesity is rapidly increasing in industrialized nations. More than 35% of American adults are now considered overweight or obese (1) , and obesity is an important contributing factor to the development of type 2 diabetes (2-4). Dyslipidemia is often observed in association with obesity and diabetes and is a significant contributor to the increased mortality observed in diabetic patients (5, 6) . Characteristics of type 2 diabetes include impaired glucose disposal, diminished insulin production, and increased hepatic glucose output. The mechanisms by which obesity contributes to these phenotypes remain unclear (7) .
Signaling via protein kinase A (PKA) plays an important role in regulating metabolism and body weight (8) . PKA is activated by cAMP and comprises two regulatory and two catalytic subunits (8) . Four regulatory isoforms (RI␣, RI␤, RII␣, and RII␤) and two catalytic isoforms (C␣ and C␤) are expressed in the mouse, and each is encoded by a separate gene. The RII␤ subunit is expressed principally in three tissues known to regulate energy homeostasis: brown adipose tissue, white adipose tissue, and brain (8, 9) . Recent studies suggest that the induction of PKA in certain tissues may decrease obesity. For example, activation of the adipose-specific ␤-adrenergic receptor (10) , which signals via PKA, decreases obesity in both genetically obese (ob/ob) (11, 12) and diet-induced obese mice (13) , suggesting that signaling mechanisms through this pathway are important in preventing obesity.
Studies in mice lacking a specific PKA subunit, RII␤, have revealed an unexpected role for this protein in regulating energy balance (9) . RII␤ knockout mice (RII␤ Ϫ/Ϫ ) remain remarkably lean even when challenged with a high-fat diet (9) . These animals have increased metabolic activity, manifested by increases in body temperature, uncoupling protein 1 concentration, and lipid hydrolysis. Biochemical studies have shown that loss of RII␤ was compensated by increased RI␣ regulatory subunit, which is more sensitive to cAMP activation and results in a net increase in basal PKA activity (14) . These studies suggest that increasing basal PKA activity in adipose tissue and brain ameliorates obesity.
In this study, we sought to determine whether loss of RII␤ influences the development of diabetes and dyslipidemia associated with obesity. Wild-type and RII␤ Ϫ/Ϫ mice, maintained on the C57BL/6 genetic background strain, were fed a high-fat, high-carbohydrate diet. This diet is known to induce obesity and diabetes in C57BL/6 mice (15, 16) . RII␤ Ϫ/Ϫ mice were resistant to weight gain and hyperinsulinemia. In vivo insulin sensitivity and glucose disposal were dramatically improved in the RII␤ Ϫ/Ϫ mice, as were plasma lipid profiles. When mice were corrected for differences in body weight, improved insulinmediated glucose disposal was still observed in the RII␤ Ϫ/Ϫ mice, suggesting an obesity-independent effect of RII␤ on promoting insulin resistance. We suggest that PKA activity in both adipose tissue and brain is important for determining body composition, food intake, and diabetogenic parameters. Thus, PKA is an attractive therapeutic target for preventing and treating obesity and the coinciding disorders of insulin resistance and dyslipidemia.
Levels of the PKA subunits, RII␤, RII␣, and RI␣, were evaluated using procedures as described (9) . Briefly, brown adipose tissue, testis, or islet protein homogenates (40 g per lane) were resolved by 10% SDS-PAGE and transferred to nitrocellulose membranes. Uniformity of protein loading was confirmed by Coomassie Blue staining (not shown). Polyclonal antibodies raised to recombinant murine PKA subunits were provided by J. Scott and diluted as follows: RII␤ 1:10,000; RII␣ 1:1,000; and RI␣ 1:200. Primary antibodies were visualized using horseradish peroxidase-coupled goat antirabbit Ig (1:40,000) and enhanced chemiluminescence (Amersham). Hepatic lipid measurements. Lipids were extracted from mouse livers as described (19) . Triglyceride and cholesterol content were then measured on extracted samples using the colorimetric kits. Statistics. Data are presented as means Ϯ SE. Differences between genotypes were determined using the Student's t test. Pearson's correlation coefficients were used to assess relations between adiposity and glucose disposal. P Ͻ 0.05 was accepted as statistically significant.
RESULTS

Longitudinal analysis of RII␤
؊/؊ mice. Body weights increased steadily for male mice of both genotypes fed the diabetogenic diet (Study 1) (Fig. 1A) . RII␤ Ϫ/Ϫ mice were 20% lighter than wild-type mice at initial (0 weeks) and final (15 weeks) time points (Table 1) . Although mice of both genotypes showed comparable changes in percent body weight by the end of the study (e.g., 60% at 15 weeks), RII␤ Ϫ/Ϫ mice gained weight more slowly than did wild-type mice.
Leptin levels reflected differences in body weights for RII␤ Ϫ/Ϫ and wild-type mice. Among mice fed rodent chow (0 weeks), leptin levels were threefold lower for RII␤ Ϫ/Ϫ mice than for wild-type mice (Table 1 and Fig. 1B ). Leptin 
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؊/؊ MICE levels increased when mice were fed the high-fat diet, but the pattern of response differed between genotypes. Whereas wild-type mice showed an early and robust increase in leptin, leptin elevations were delayed in RII␤ Ϫ/Ϫ mice. By 3 weeks, leptin levels in wild-type mice increased fourfold (6.2 Ϯ 1.1 to 27.6 Ϯ 2.0 ng/ml; P Ͻ 0.001), whereas those in RII␤ Ϫ/Ϫ mice showed only a twofold increase (2.1 Ϯ 0.1 to 5.2 Ϯ 1.0 ng/ml; P Ͻ 0.005). These changes are consistent with the delayed weight gain of RII␤ Ϫ/Ϫ mice compared with controls. By 12-15 weeks, leptin levels were comparable between strains.
Body weights correlated significantly with leptin levels for both wild-type (r ϭ 0.88, P Ͻ 0.01) and RII␤ Ϫ/Ϫ (r ϭ 0.95, P Ͻ 0.008) mice over the 15 weeks of study. Food intake was measured to determine whether differences in weight and leptin levels were reflected as differences in caloric consumption. Average food intake over the 15-week period was higher for wild-type mice than for RII␤ Ϫ/Ϫ mice (15.4 Ϯ 0.6 vs. 13.8 Ϯ 0.6 cal/mouse/day, P ϭ 0.06). However, when food consumption was corrected to differences in body weight, the RII␤ Ϫ/Ϫ mice actually consumed more calories. Wild-type mice consumed 0.37 Ϯ 0.02 cal/g mouse/day, whereas RII␤ Ϫ/Ϫ mice consumed 0.44 Ϯ 0.02 cal/g mouse/day (P ϭ 0.005). Since the leptin levels were significantly different between the genotypes (Fig. 1B) , leptin levels did not reflect food consumption in these mice.
Mice fed rodent chow (0 weeks) had plasma glucose levels that were comparable between genotypes (Table 1 and Fig. 1C ). When the mice were fed the high-fat diet, glucose levels increased in both strains. Glucose levels for wild-type mice increased from 131 to 215 mg/dl, with final values after 15 weeks of 184 Ϯ 8 mg/dl (P Ͻ 0.05 vs. 0 weeks). RII␤ Ϫ/Ϫ mice exhibited a steady but gradual increase in glucose with time on the diet to a final value of 205 Ϯ 18 mg/dl (P Ͻ 0.001 vs. week 0). Except for the time point at 3 weeks (P Ͻ 0.005), plasma glucose levels did not differ significantly between genotypes.
In contrast to glucose, plasma insulin levels were consistently higher in wild-type than in RII␤ Ϫ/Ϫ mice (Fig. 1D ). Initial insulin values were 26% higher for wild-type mice (Table 1) and were approximately two-to fivefold higher at all other time points. Final insulin levels were significantly higher than initial levels for both wild-type (P Ͻ 0.001) and RII␤ Ϫ/Ϫ (P Ͻ 0.001) mice. Overall, both genotypes were able to adjust insulin levels to compensate for increases in glucose, but insulin requirements were higher for wild-type mice than for RII␤ Ϫ/Ϫ mice. The observation that RII␤ Ϫ/Ϫ mice were able to achieve glucose compensation with less insulin suggests improved insulin sensitivity in this strain. This is better reflected by examining the ratio of insulin to glucose, which would be expected to be higher for insulin-resistant mice. Indeed, over the course of the study, the average ratio of insulin to glucose for wild-type mice was 40% higher than that for RII␤ Ϫ/Ϫ mice (Fig. 1C inset) . However, another interpretation of the reduced insulin levels in RII␤ Ϫ/Ϫ mice may be that loss of RII␤ causes defects in insulin secretion. Immunoblotting of islet tissue taken from wild-type mice showed that RII␤ protein is absent from this tissue (Fig. 2) . Thus, it is unlikely that RII␤ contributes directly to signaling pathways in ␤-cells involved with insulin secretion. Taken together, these data are consistent with increased insulin sensitivity in the RII␤ Ϫ/Ϫ strain.
Diabetogenic phenotypes of RII␤
؊/؊ mice. An additional study (Study 2) was performed to confirm whether RII␤ Ϫ/Ϫ mice showed improved insulin sensitivity and glucose responsiveness as compared with wild-type mice. In addition, because of the sex dimorphism in obesity and diabetes often seen among mice (21, 22) , we examined males and females separately. Body weights and adiposities were recorded for diabetogenic diet-fed mice, and IPGTT and insulin sensitivity tests were performed. Finally, the consequences of RII␤ ablation on plasma lipoprotein profiles were determined. Body weight and adiposity. At week 0 of the study (8 weeks of age), body weights for RII␤ Ϫ/Ϫ mice were 15% lower than those for wild-type mice within each sex (Fig.  3) , consistent with data obtained for the older males ( 0.8 g (P Ͻ 0.001) and females weighed 15.6 Ϯ 0.7 vs. 19.7 Ϯ 0.5 g (P Ͻ 0.0006) for RII␤ Ϫ/Ϫ and wild-type mice, respectively. When they were fed the diabetogenic diet, mice of both sexes experienced steady increases in body weight. Final body weights were 27 Ϯ 1 vs. 43 Ϯ 2 g for male RII␤ Ϫ/Ϫ versus wild-type mice, respectively (P Ͻ 0.0002), and 23 Ϯ 1 vs. 31 Ϯ 4 g for female RII␤ Ϫ/Ϫ versus wild-type mice, respectively (P Ͻ 0.03). RII␤ Ϫ/Ϫ mice of both sexes maintained lighter phenotypes than wild-type mice when fed either the rodent chow diet or the diabetogenic diet.
In this study, a sex difference was observed. The percent body weight gain between genotypes fed the diabetogenic diet for 15 weeks was greater in male mice (41%) than in female mice (14%). Thus, in our study, sex, age, and genotype influenced the extent of body weight gain in response to the diabetogenic diet.
Based on initial characterizations of RII␤ Ϫ/Ϫ mice (9), differences in actual body weights between genotypes were probably due to differences in adiposity. To test this, the investigators killed male and female mice (Study 2) after 15 weeks of consuming the diabetogenic diet, and four fat pad pairs (reproductive, inguinal, retroperitoneal/ renal, and intrascapular brown adipose tissue) were collected and weighed (Fig. 4) . Loss of RII␤ resulted in reduced adiposities involving all fat pads with the exception of brown adipose tissue in females. Glucose disposal. The effect of RII␤ deficiency on totalbody glucose disposal in an IPGTT was examined in chow-fed male mice and diabetogenic diet-fed mice of both sexes (Fig. 5) . Results show that loss of RII␤ improves glucose disposal, regardless of dietary treatment. Compared with wild-type mice, RII␤ Ϫ/Ϫ mice displayed lower glucose levels at all time points after glucose injection. Differences between genotypes matched for age and fed the chow diet (Fig. 5A) were not statistically significant, but a trend for improved glucose disposal by RII␤ Ϫ/Ϫ mice was seen. Glucose excursion was significantly reduced in female RII␤ Ϫ/Ϫ mice compared with wild-type mice fed the diabetogenic diet (Fig. 5B) . Differences were most dramatic for diabetogenic diet-fed male ؊/؊ (f) mice were killed after a 4-h fast and individual fat depots were removed and weighed. White adipose tissue fat pads measured were as follows: reproductive (epididymal or periuterine), inguinal, retroperitoneal plus perirenal, and the sum of these tissue weights (WAT). Intrascapular brown adipose tissue (BAT) weights were also measured. Values are presented as means ؎ SE for n ‫؍‬ 4 -7 mice per set. Significant differences between genotypes were seen at *P < 0.05 and **P < 0.001.
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؊/؊ MICE mice (Fig. 5C ). In RII␤ Ϫ/Ϫ mice, glucose levels returned to baseline values 120 min after glucose injection; in wildtype mice, this did not occur until 240 min after injection. The profile of glucose disposal remained the same between diabetogenic diet-and chow diet-fed RII␤ Ϫ/Ϫ mice (compare Fig. 5A with 5C ), indicating that loss of RII␤ completely prevented the induction of diet-induced glucose intolerance. Insulin sensitivity. To assess insulin-stimulated glucose clearance directly, in vivo insulin-mediated glucose disposal assays were performed (Fig. 6 ). For chow-fed, age-matched (24 weeks old) male mice, no significant difference was observed between genotypes. Feeding wild-
FIG. 5. IPGTT for wild-type (E) and RII␤ ؊/؊ (F) mice fed the chow (A) or diabetogenic diet (B and C).
Chow-fed male mice, 16 weeks old, were subjected to IPGTT after an overnight fast (A). Female (B) or male (C) mice were fed the diabetogenic diet for 14 weeks and fasted overnight before the IPGTT was performed. Values are presented as means ؎ SE for n ‫؍‬ 5-6 mice per set. Significant differences between genotypes were seen at *P < 0.05 and **P < 0.001.
FIG. 6. Insulin-mediated glucose disposal measurements in chow dietand diabetogenic diet-fed mice. A: Insulin-mediated glucose disposal for wild-type (WT) or RII␤
؊/؊ mice fed the chow or diabetogenic diet. Chow-fed male mice were subjected to the assay at 16 weeks of age (left panel). Male and female mice were fed the diabetogenic diet for 12 weeks before performing the insulin sensitivity assay (right panel). Mice from both Study 1 and Study 2 were used in this experiment. B: Relation between adipose weight and insulin-mediated glucose disposal for male or female mice fed the diabetogenic diet. Total weights of all white adipose depots (WAT) were used to estimate adiposity.
Wild-type mice are presented by the open symbols and RII␤
؊/؊ mice are presented by the filled symbols. C: Insulin-mediated glucose disposal per gram body weight for mice fed the chow or diabetogenic diet. Values are presented as means ؎ SE for n ‫؍‬ 4 -13 mice per set. Significant differences between genotypes were seen at *P < 0.05 and **P < 0.001. type mice the diabetogenic diet resulted in a marked reduction in the percent of glucose cleared after insulin injection. Importantly, this diet-induced reduction was not observed in RII␤ Ϫ/Ϫ mice (Fig. 6A) . Among diabetogenic diet-fed RII␤ Ϫ/Ϫ male and female mice, the clearance of glucose after insulin injection was the same as for animals fed the chow diet, demonstrating that these mice are resistant to the development of diet-induced insulin resistance.
To determine whether differences in adiposity between genotypes could solely account for differences in insulin sensitivity, insulin-stimulated glucose clearance was assessed as a function of total white adipose tissue weight for both genotypes fed the diabetogenic diet (Fig. 6B) . Results demonstrate that the percent glucose clearance was negatively correlated with adiposity only for wild-type mice (r ϭ Ϫ0.70, P Ͻ 0.002). This relationship was modified by the RII␤ gene deletion, because no correlation was seen between these parameters for RII␤ Ϫ/Ϫ mice. The inability to obtain RII␤ Ϫ/Ϫ mice with adiposity comparable to wild-type mice prevents us from confirming whether the improved insulin sensitivity is solely due to reduced adiposity or whether there are independent effects of RII␤ deficiency on improving insulin-mediated glucose disposal. In an attempt to address this, we evaluated insulinmediated glucose disposal per gram mouse weight for chow versus diabetogenic diet-fed mice. Results demonstrate that in diabetogenic diet-fed wild-type mice, decreased glucose disposal per gram body weight is observed (P Ͻ 0.02) (Fig. 6C) . This supports the concept that the diet itself increases insulin resistance: i.e., if insulin resistance was proportional only to increased body weight, similar values between chow diet-and diabetogenic diet-fed mice would be expected. RII␤ Ϫ/Ϫ mice showed no weight-adjusted reduction in insulin-mediated glucose disposal in response to the diabetogenic diet. Therefore, we conclude that the diabetogenic diet increases resistance to insulin-mediated glucose disposal and that loss of RII␤ ameliorates this effect. Plasma lipids. Dyslipidemia is often observed in conjunction with obesity and diabetes. Plasma total cholesterol levels were significantly higher in wild-type mice than in RII␤ Ϫ/Ϫ male mice fed the diabetogenic diet for 15 weeks (250 Ϯ 37 and 159 Ϯ 12 mg/dl for wild-type and RII␤ Ϫ/Ϫ mice, respectively; P ϭ 0.02). Female mice showed significantly lower levels of plasma total cholesterol than males (P Ͻ 0.05), and there was a trend toward lower levels in RII␤ Ϫ/Ϫ mice than in wild-type mice (132 Ϯ 17 and 117 Ϯ 10 mg/dl). No significant differences in plasma triglyceride or free fatty acid levels were observed between genotypes.
Plasma lipoprotein profiles were determined for diabetogenic diet-fed wild-type and RII␤ Ϫ/Ϫ mice (Fig. 7) , and the results were consistent with total cholesterol levels. Although all mice showed an HDL fraction of comparable size and abundance, male RII␤ Ϫ/Ϫ mice had a dramatic decrease in the VLDL and LDL fraction as compared with wild-type mice. Female RII␤ Ϫ/Ϫ mice also showed reduced VLDL/LDL cholesterol compared with wild-type mice, although the difference was not as striking.
Finally, quantification of plasma apolipoproteins for male mice fed the diabetogenic diet was performed to assess how RII␤ deficiency influences lipoprotein composition. Consistent with our lipoprotein profile analysis, no differences in apoA-I, the principal protein associated with HDL, was observed. However, we also did not observe any differences in either apoB48 or apoB100, which are proteins associated with VLDL/LDL particles. In contrast, plasma levels of apoE, a protein associated with both VLDL and HDL in rodents (23), was reduced twofold in RII␤ Ϫ/Ϫ mice (P Ͻ 0.006). The higher apoE level in wild-type males is consistent with the presence of ␤-VLDL as the major lipoprotein within the VLDL/LDL peak (Fig.  7B) . ␤-VLDL particles contain abundant amounts of apoE and cholesterol, with a relatively little triglyceride (24) . Further studies are needed to improve resolution between lipoprotein fractions and to determine actual chemical compositions. Overall, RII␤ knockout mice were protected from the diet-induced dyslipidemia that developed in wild-type males. Hepatic lipid content. Hepatic cholesterol and triglyceride levels were quantified for male mice fed the diabetogenic diet for 15 weeks. Liver cholesterol levels were similar between genotypes (ϳ3.1 mg cholesterol/g liver), whereas the RII␤ Ϫ/Ϫ mice showed a 2.5-fold reduction in triglyceride levels (wild-type : 
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؊/؊ MICE relatively resistant to diet-induced fatty livers, as reported earlier on a different diet (9) .
DISCUSSION
We show that a major consequence of PKA RII␤ deficiency is to protect mice from obesity, insulin resistance, and dyslipidemia induced by a high-fat, high-carbohydrate diet. RII␤ Ϫ/Ϫ mice displayed reduced weight gain, lower insulin levels, and improved total-body glucose disposal as compared with wild-type mice fed a high-fat, high-sucrose diet. The magnitude of effect was dependent on both the sex and age of the mice studied. These findings demonstrate that targeting RII␤ activity would provide an excellent therapy to reduce both obesity and metabolic disorders associated with obesity.
RII␤ expression is limited to a few tissues, which include white and brown adipose tissue and brain (8, 25) . In murine brain, targeted disruption of the RII␤ gene results in marked reduction of total PKA activity in the striatum, cortex, and hypothalamus (26, 27) . In adipose tissue, RI␣ substitutes for RII␤ and causes a four-to fivefold increase in basal PKA activity, resulting in chronic stimulation of thermogenesis and basal lipolysis. Since RII␤ is absent from pancreatic islets, effects on insulin secretion in response to circulating glucose would be indirect. Taken together, these findings imply that PKA activity in both brain and adipose tissue is involved in regulating both susceptibility to adiposity and insulinmediated glucose clearance.
There are several mechanisms that are likely contributing to the lean phenotype observed in the RII␤ Ϫ/Ϫ mice. Possible contributing factors include increased thermogenesis, increased lipolysis, and decreased food intake. RII␤ Ϫ/Ϫ mice fed normal chow diets have elevations in thermogenesis (9) and basal lipolysis (28) , both of which may promote leanness. These attributes may contribute significantly to the leanness seen in diabetogenic diet-fed mice, since food intake was similar based on total body weight and significantly higher based on gram mouse weight for the RII␤ Ϫ/Ϫ mice. Therefore, differences in caloric consumption cannot fully account for the unusual leanness in the RII␤ Ϫ/Ϫ mice. Leptin was markedly reduced in RII␤ mutants compared with wild types at the onset of this study and during most of the time on the diabetogenic diet. Leptin is a long-term satiety hormone secreted by adipocytes in proportion to adiposity (29 -31) . Since the RII␤ Ϫ/Ϫ mice ate comparably to the wild-type mice despite having lower leptin levels, this suggests that RII␤ deficiency dysregulates leptin-induced satiety responses.
It is likely that RII␤ Ϫ/Ϫ mice are protected against developing insulin resistance when fed the diabetogenic diet at least in part because of their relative resistance to diet-induced obesity. We were unable to obtain a sufficient number of RII␤ Ϫ/Ϫ mice that had white adipose tissue weights similar to those of wild-type mice. The availability of this population would allow us to directly test whether RII␤ has direct effects on influencing insulin resistance. However, when we corrected insulin-mediated glucose disposal to differences in body weights, we observed that diabetogenic diet-fed RII␤ Ϫ/Ϫ mice retained a similar amount of insulin-mediated glucose disposed per gram mouse weight as compared with chow-fed RII␤ Ϫ/Ϫ mice, whereas wild-type mice showed decreased glucose disposal per gram mouse weight. This finding suggests that elimination of RII␤ improves insulin-mediated glucose disposal through a mechanism independent of alterations in body composition. PKA is known to antagonize insulin's activation of the mitogen-activated protein kinase cascade, probably by blocking events at the levels of ras or raf (32) . It is possible that this action requires an RII␤-containing PKA holoenzyme and cannot be subserved by the compensating RI␣ isoform present in RII␤ knockout mice. Insulin action in adipose may thus be enhanced in RII␤ Ϫ/Ϫ mice due to the absence of PKA-mediated counterregulation of insulin signaling.
Elevations in LDL and VLDL occur commonly among mice fed high-fat diets (33) (34) (35) (36) . In fact, the major lipoprotein increase is seen in ␤-VLDL (36), cholesterol-rich particles containing both apoB and apoE (24) . Unique to this report was the marked loss of lipoproteins from the VLDL/LDL fraction in the RII␤ Ϫ/Ϫ mice. Concomitant with this loss was a twofold reduction in plasma levels of apoE, supporting the concept that ␤-VLDL is nearly absent in RII␤ Ϫ/Ϫ animals fed a high-fat diet. Remaining apoE is presumed to reside in the HDL fraction (35) . It remains to be determined whether the difference in ␤-VLDL between RII␤ Ϫ/Ϫ and wild-type mice results from direct effects of RII␤ on lipoprotein production or clearance, as opposed to secondary effects arising from differences in diet-induced insulin resistance.
A consistent feature of obesity and insulin resistance in rodents is sex dimorphism. Male mice are more susceptible to body weight gain and diabetes due to eating high-fat diets (22) or to genetic mutations (21) as compared with female mice. Molecular mechanisms for this difference are not clear but may involve the expression of hepatic sex steroid sulfotransferases (37) . Here, female RII␤ Ϫ/Ϫ mice gained proportionally more body weight than male mice, although they retained insulin sensitivity. This is a somewhat unusual finding among diabetic rodent models and may reflect a role for PKA in modulating hormonal control of body weight.
In early studies of RII␤ Ϫ/Ϫ mice from the mixed 129 and C57BL/6 genetic background, we found greater disparities in diet-induced weight gain between genotypes than were seen for the Ͼ97% C57BL/6 background mice presented in this report. This may be due to allelic contributions from 129, known to present a lean phenotype in other studies. Thus, the influence of the RII␤ mutation is magnified in mice containing 129 genes and demonstrates that the influence of RII␤ function is dependent on unknown loci present within the 129 genome. Importantly, however, the effects of the RII␤ mutation on body weight are significant regardless of genetic background, which suggests that targeting this gene in human therapies will benefit a range of human populations.
Overall, our studies support independent roles for PKA RII␤ in the modulation of weight gain and insulin resistance associated with obesity. It remains to be determined which of these effects are modulated by PKA activity within adipose versus central nervous system-mediated responses. Our results suggest that alleles at loci coding for PKA regulatory subunits should be included in the list of candidate genes determining susceptibility to obesity and diabetes associated with obesity.
